The IPV Vaccines Market is estimated to be valued at US$173.6 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
IPV vaccines are vaccines used for immunizing people against the poliomyelitis. It is given by injection and helps in preventing individuals from contracting the poliovirus which causes ... Read more
The global Ipv Vaccines Market is estimated to be valued at US$ 188.36 Mn or Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
IPV vaccines provide immunization against polio. They help protect children and adults from polio, a crippling and potentially deadly infectious disease.
IPV (Inactivated Polio Vaccine) prevents poliomyelitis, also known as polio. Polio is a highly infectious viral disease that can affect the nervous system causing weakness and paralysis. The vaccine protects individuals against all three polioviruses. With initiative to eradicate polio globally, vaccination is important.
The global IPV Vaccines Market is estimated to be valued at US$ 188.36 million in 2023 and is expected to exhibit a CAGR of 8.5% ... Read more
